Egalet Announces Update On Clinical Development Plan For Abuse-Deterrent Morphine Egalet-001

By: via Benzinga
Egalet Corporation (Nasdaq: EGLT) (Egalet) today announced an update to the clinical development plan for Egalet-001, an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.